sotrovimab

Officials limit an antibody therapy, saying it’s ineffective against BA.2 variant of Omicron
Stat
Sun, 03/27/22 - 04:00 pm
Vir Biotechnology
GSK
monoclonal antibodies
sotrovimab
COVID-19
Omicron BA.2
FDA
Two new drugs added to WHO list of COVID-19 therapies
Pharmaforum
Mon, 01/17/22 - 10:26 am
WHO
COVID-19
Eli Lilly
olumiant
GSK
Vir Biotechnololgy
sotrovimab
Pair of R&D updates bolster GSK ahead of investor meeting
Pharmaforum
Tue, 06/22/21 - 10:52 am
GSK
COVID-19
sotrovimab
Halozyme
investors